Who owns PFEWhat PFE owns
What Pfizer Inc. owns
The company's own 13F portfolio · as of 2026-03-31 · long US-listed stakes only — private holdings, bonds and cash are not disclosable on a 13F
$238.8M
disclosed stock portfolio
18
positions
24.1%
in ORIC
Positions, as of 2026-03-31
ordered by filed value · % of book = share of the disclosed stock portfolio · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | ORICORIC PHARMACEUTICALS INC | 4.8M | $57.7M | 24.1% |
| 2 | ALLOALLOGENE THERAPEUTICS INC | 22.0M | $49.8M | 20.9% |
| 3 | ARVNARVINAS INC | 3.5M | $34.9M | 14.6% |
| 4 | CELCCELCUITY INC | 295,652 | $31.3M | 13.1% |
| 5 | ZURA BIO LTD | 2.8M | $16.8M | 7.1% |
| 6 | WAVE LIFE SCIENCES LTD | 1.9M | $11.9M | 5% |
| 7 | PYXSPYXIS ONCOLOGY INC | 7.0M | $9.2M | 3.9% |
| 8 | CRBUCARIBOU BIOSCIENCES INC | 4.7M | $8.3M | 3.5% |
| 9 | SPROSPERO THERAPEUTICS INC | 2.4M | $5.5M | 2.3% |
| 10 | BIOHAVEN LTD | 505,645 | $4.2M | 1.8% |
| 11 | CRDFCARDIFF ONCOLOGY INC | 2.4M | $3.7M | 1.6% |
| 12 | ZNTLZENTALIS PHARMACEUTICALS INC | 953,834 | $2.0M | 0.8% |
| 13 | NXTCNEXTCURE INC | 153,354 | $1.5M | 0.6% |
| 14 | AGMBAGOMAB THERAPEUTICS NV | 75,000 | $813,750 | 0.3% |
| 15 | QTTBQ32 BIO INC | 101,618 | $736,731 | 0.3% |
| 16 | BOLTBOLT BIOTHERAPEUTICS INC | 31,305 | $137,116 | 0.1% |
| 17 | DNAGINKGO BIOWORKS HOLDINGS INC | 2,928 | $17,363 | 0% |
| 18 | SENS1GBPSENSEONICS HLDGS INC | 2,171 | $14,242 | 0% |
Source: SEC Form 13F-HR filed by Pfizer Inc (CIK 78003), reporting period 2026-03-31. Values are quarter-end filed marks. Research, not investment advice.